Literature DB >> 22353613

Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension.

Preet S Chadha1, Friederike Zunke, Hai-Lei Zhu, Alison J Davis, Thomas A Jepps, Søren P Olesen, William C Cole, James D Moffatt, Iain A Greenwood.   

Abstract

KCNQ4-encoded voltage-dependent potassium (Kv7.4) channels are important regulators of vascular tone that are severely compromised in models of hypertension. However, there is no information as to the role of these channels in responses to endogenous vasodilators. We used a molecular knockdown strategy, as well as pharmacological tools, to examine the hypothesis that Kv7.4 channels contribute to β-adrenoceptor-mediated vasodilation in the renal vasculature and underlie the vascular deficit in spontaneously hypertensive rats. Quantitative PCR and immunohistochemistry confirmed gene and protein expression of KCNQ1, KCNQ3, KCNQ4, KCNQ5, and Kv7.1, Kv7.4, and Kv7.5 in rat renal artery. Isoproterenol produced concentration-dependent relaxation of precontracted renal arteries and increased Kv7 channel currents in isolated smooth muscle cells. Application of the Kv7 blocker linopirdine attenuated isoproterenol-induced relaxation and current. Isoproterenol-induced relaxations were also reduced in arteries incubated with small interference RNAs targeted to KCNQ4 that produced a ≈60% decrease in Kv7.4 protein level. Relaxation to isoproterenol and the Kv7 activator S-1 were abolished in arteries from spontaneously hypertensive rats, which was associated with ≈60% decrease in Kv7.4 abundance. This study provides the first evidence that Kv7 channels contribute to β-adrenoceptor-mediated vasodilation in the renal vasculature and that abrogation of Kv7.4 channels is strongly implicated in the impaired β-adrenoceptor pathway in spontaneously hypertensive rats. These findings may provide a novel pathogenic link between arterial dysfunction and hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353613     DOI: 10.1161/HYPERTENSIONAHA.111.187427

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

1.  Effects of the Kv7 voltage-activated potassium channel inhibitor linopirdine in rat models of haemorrhagic shock.

Authors:  Sean P Nassoiy; Favin S Babu; Heather M LaPorte; Kenneth L Byron; Matthias Majetschak
Journal:  Clin Exp Pharmacol Physiol       Date:  2018-04-27       Impact factor: 2.557

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 3.  Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth.

Authors:  W F Jackson
Journal:  Adv Pharmacol       Date:  2016-08-17

4.  Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.

Authors:  Lin Li; Jinxiu Li; Yan Zuo; Danny Dang; Jeffrey A Frost; Qing Yang
Journal:  J Pain       Date:  2018-11-22       Impact factor: 5.820

5.  Activation of Kv 7 channels as a novel mechanism for NO/cGMP-induced pulmonary vasodilation.

Authors:  Gema Mondéjar-Parreño; Javier Moral-Sanz; Bianca Barreira; Alicia De la Cruz; Teresa Gonzalez; Maria Callejo; Sergio Esquivel-Ruiz; Daniel Morales-Cano; Laura Moreno; Carmen Valenzuela; Francisco Perez-Vizcaino; Angel Cogolludo
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

6.  Activation of KCNQ Channels Suppresses Spontaneous Activity in Dorsal Root Ganglion Neurons and Reduces Chronic Pain after Spinal Cord Injury.

Authors:  Zizhen Wu; Lin Li; Fuhua Xie; Junhui Du; Yan Zuo; Jeffrey A Frost; Susan M Carlton; Edgar T Walters; Qing Yang
Journal:  J Neurotrauma       Date:  2017-02-27       Impact factor: 5.269

7.  KV 7 channels are involved in hypoxia-induced vasodilatation of porcine coronary arteries.

Authors:  E R Hedegaard; B D Nielsen; A Kun; A D Hughes; C Krøigaard; S Mogensen; V V Matchkov; O Fröbert; U Simonsen
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

8.  From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group.

Authors:  Sigrid Marie Blom; Mario Rottländer; Jan Kehler; Christoffer Bundgaard; Nicole Schmitt; Henrik Sindal Jensen
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

9.  Cardiovascular responses to retigabine in conscious rats--under normotensive and hypertensive conditions.

Authors:  L V Fretwell; J Woolard
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.

Authors:  Lioubov I Brueggemann; Alexander R Mackie; Leanne L Cribbs; Jessica Freda; Abhishek Tripathi; Matthias Majetschak; Kenneth L Byron
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.